ClinicalTrials.gg
RecruitingNCT07272031Updated Aug 13, 2026

Office Massage Effects on HRV and Stress

An interventional study of Head Massage Intervention and Cervical Area Massage Intervention in Occupational Health, Autonomic Nervous System (ANS) Functioning and Mood State and Stress, sponsored by Riga Stradins University. Recruiting at 1 site in Latvia. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-13.

Sponsored by Riga Stradins University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Non-randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This study is a randomized controlled trial designed to investigate which of three short office massage types (head, neck/shoulder area, or hand) is most effective for reducing chronic stress in women who perform sedentary office work.

Many sedentary female office employees experience long-term tension and work-related strain, which can affect the body's ability to recover. The investigators are testing whether a 15-minute massage, performed twice a week for four weeks, can help restore balance within the body.

The investigators will evaluate the impact of these massages using Heart Rate Variability (HRV)-an objective measure that shows how well the body manages stress (autonomic nervous system balance)-as well as analyzing participants' self-reported levels of perceived stress, sleep quality, and overall well-being. Participants receiving massage will be compared to a control group engaging in quiet rest.

02

Conditions studied

  • Occupational Health
  • Autonomic Nervous System (ANS) Functioning and Mood State
  • Stress
03

In context

Lead sponsor

Riga Stradins University is the lead sponsor of 19 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Biological females aged 18 years or older. Currently working in an office job with at least 75% of the working day spent sitting (sedentary work).

Self-reported regular menstrual cycle (cycle length 21-35 days). Able to attend all scheduled intervention sessions (8 sessions over 4 weeks). Able to provide to participate in the study.

Exclusion criteria

Exclusion Criteria:

Current pregnancy or breastfeeding. Diagnosis of cardiovascular diseases (e.g., heart failure, cardiac arrhythmias, deep vein thrombosis) or presence of a pacemaker Endocrine or metabolic disorders (e.g., insulin-dependent diabetes, hyperthyroidism, or other thyroid dysfunctions) Active cancer or receiving active cancer treatment (e.g., chemotherapy, radiation therapy) History of major surgery or trauma in the head, neck, or upper extremities within the last 3 months Current diagnosis of a major psychiatric disorder (e.g., major depressive disorder, bipolar disorder) Regular use of medications affecting heart rate or the nervous system (e.g., beta-blockers, ACE inhibitors, antidepressants, anxiolytics, or asthma inhalers) Current participation in another interventional clinical trial

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
140 participants (estimated)

Study arms

  • Active comparator
    Head Massage

    Duration and Frequency: 15 minutes per session, 2 times per week for 4 consecutive weeks (8 sessions total). Focus: Massage focuses on the scalp, temples, and auricles (outer ear) with the aim of stimulating cranial nerves, particularly branches of the vagus nerve. The procedure is performed by a licensed massage therapist while the participant is seated in an office chair.

    Procedure: Head Massage Intervention

  • Active comparator
    Cervical Area Massage

    Duration and Frequency: 15 minutes per session, 2 times per week for 4 consecutive weeks (8 sessions total). Focus: Deep tissue and kneading massage techniques applied primarily to the trapezius muscles, levator scapulae, and sub-occipital region (neck/shoulders). The procedure is performed by a licensed massage therapist while the participant is seated in an office chair.

    Procedure: Cervical Area Massage Intervention

  • Active comparator
    Hand Massage

    Duration and Frequency: 15 minutes per session, 2 times per week for 4 consecutive weeks (8 sessions total). Focus: Compression, rubbing, and stroking techniques applied to the palmar and dorsal surfaces of the hands, fingers, and wrists. The procedure is performed by a licensed massage therapist while the participant is seated in an office chair.

    Procedure: Hand Massage Intervention

  • Placebo comparator
    Quiet Rest Control

    Duration and Frequency: Participants are seated in the same office chair for a structured 15-minute period, 2 times per week for 4 consecutive weeks (8 sessions total). Focus: Participants are instructed to sit quietly, avoid work-related activity, and refrain from using electronic devices. This arm controls for the effect of researcher attention and time spent away from work.

    Other: Quiet Rest Control

Interventions

  • ProcedureHead Massage Intervention

    15 minutes per session, 2 times per week for 4 consecutive weeks (8 sessions total). Focus: Massage focuses on the scalp, temples, and auricles (outer ear) with the aim of stimulating cranial nerves, particularly branches of the vagus nerve. The procedure is performed by a licensed massage therapist while the participant is seated in an office chair.

  • ProcedureCervical Area Massage Intervention

    15 minutes per session, 2 times per week for 4 consecutive weeks (8 sessions total). Focus: Deep tissue and kneading massage techniques applied primarily to the trapezius muscles, levator scapulae, and sub-occipital region (neck/shoulders). The procedure is performed by a licensed massage therapist while the participant is seated in an office chair.

  • ProcedureHand Massage Intervention

    15 minutes per session, 2 times per week for 4 consecutive weeks (8 sessions total). Focus: Compression, rubbing, and stroking techniques applied to the palmar and dorsal surfaces of the hands, fingers, and wrists. The procedure is performed by a licensed massage therapist while the participant is seated in an office chair.

  • OtherQuiet Rest Control

    Participants are seated in the same office chair for a structured 15-minute period, 2 times per week for 4 consecutive weeks (8 sessions total). Focus: Participants are instructed to sit quietly, avoid work-related activity, and refrain from using electronic devices. This arm controls for the effect of researcher attention and time spent away from work.

06

What researchers measure

Primary outcomes

  1. Change from Baseline in Morning Resting Heart Rate Variability (rMSSD) at 4 Weeks

    Time frame: Baseline, Periprocedural and Week 4

  2. Change from Baseline in Perceived Stress Level (PSS-10 Score) at 4 Weeks

    Time frame: Baseline and Week 4

Secondary outcomes

  1. Sleep Quality: Assessed using the Pittsburgh Sleep Quality Index (PSQI) total score

    Time frame: Baseline and Week 4

  2. General Self-Efficacy: Assessed using the General Self-Efficacy Scale (GSE) score

    Time frame: Baseline and Week 4

  3. Emotional Well-being: Assessed using the World Health Organization Well-being Index (WHO-5) score

    Time frame: Baseline and Week 4

  4. Neck Functional Limitation: Assessed using the Neck Disability Index (NDI) score

    Time frame: Baseline and Week 4

  5. Hand and Shoulder Functionality: Assessed using the Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire score

    Time frame: Baseline and Week 4

  6. Acute Pain Intensity Change: Assessed using the Numerical Rating Scale (NRS) score (0-10) in the specific massage area

    Time frame: Periprocedural

  7. Acute Subjective Well-being Change: Assessed using the Visual Analog Scale (VAS) (0-100 mm) for relaxation, fatigue, and tension

    Time frame: Periprocedural

Other outcomes

  1. Age of Participants

    The age of participants calculated from their date of birth. Years

    Time frame: Baseline

  2. Smoking Status Categories

    The classification of participants' smoking status (e.g., Current Smoker, Former Smoker, Never Smoker). Count (Number of Participants per Category)

    Time frame: Baseline

  3. Body Mass Index (BMI)

    Body Mass Index, calculated from weight and height. kg/m2

    Time frame: Baseline

  4. Duration of Sedentary Work Experience

    The total duration of sedentary work experience. Years

    Time frame: Baseline

  5. Family and Parental Status Categories

    The classification of participants based on their family and parental status (e.g., Married, Unmarried, With Children, Without Children). Count (Number of Participants per Category)

    Time frame: Baseline

  6. Total Physical Activity Level (IPAQ)

    Total physical activity level score calculated using the International Physical Activity Questionnaire (IPAQ) short form. Metabolic Equivalent of Task (MET) -minutes/week

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • The Red Cross Medical College of Rīga Stradiņš University
    Riga, Latvia LV-1007, Latvia
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2026 (actual). Primary completion is estimated for Sep 2026, 8 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 18, 2025
First posted
Dec 9, 2025
StartActual
Jan 5, 2026
Primary completionEst.
Sep 6, 2026
CompletionEst.
Sep 30, 2026
Last update
Aug 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07272031
Lead sponsor
Riga Stradins University
Responsible party
Una Veseta (Lead Researcher, Riga Stradins University) — Principal investigator
First posted
Dec 9, 2025
Start date
Jan 5, 2026
Primary completion
Sep 6, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Aug 13, 2026

Study contacts

Una Veseta, PhD
Contact
una.veseta@rsu.lv
+37129172627

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion